Day | Mean no. (range) of An. gambiae | Mean no. (range) of Cx. quinquefasciatus | ||||
---|---|---|---|---|---|---|
Ivermectin group | Placebo group | p-value* | Ivermectin group | Placebo group | p-value* | |
0 | 48.8 (36–50) | 48.6 (40–50) | NS | 31.9 (13–50) | 31.3 (8–50) | NS |
1 | 45.5 (28–50) | 48.3 (40–50) | NS | 31.1 (11–50) | 31.2 (8–50) | NS |
2 | 25.4 (9–45) | 47.2 (40–50) | <0.001 | 30.7 (11–50) | 30.9 (7–50) | NS |
3 | 16.7 (0–37) | 46.4 (40–50) | <0.001 | 30.1 (11–49) | 30.7 (7–50) | NS |
4 | 10.4 (0–18) | 45.7 (40–50) | <0.001 | 29.9 (11–49) | 30.7 (7–50) | NS |
5 | 6.5 (0–14) | 44.9 (39–49) | <0.001 | 29.5 (11–49) | 30.3 (7–50) | NS |
6 | 5.0 (0–14) | 44.3 (39–49) | <0.001 | 29.1 (10–49) | 29.6 (7–50) | NS |
7 | 2.9 (0–10) | 42.3 (38–49) | <0.001 | 28.9 (10–49) | 29.3 (7–50) | NS |
8 | 2.4 (0–10) | 33.3 (20–49) | <0.001 | 27.9 (10–48) | 27.9 (6–50) | NS |
9 | 1.7 (0–5) | 27.8 (5–43) | <0.001 | 27.5 (9–48) | 27.5 (6–50) | NS |
10 | 1.5 (0–4) | 23.3 (1–39) | <0.001 | 26.5 (9–48) | 27.1 (5–50) | NS |
11 | 1.3 (0–4) | 21.3 (0–36) | < 0.001 | 25.0 (9–48) | 26.1 (5–48) | NS |
12 | 0.8 (0–2) | 16.0 (0–36) | < 0.001 | 20.5 (0–48) | 21.1 (0–48) | NS |